Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Oct 2019 15:32

RNS Number : 2877Q
Ideagen PLC
17 October 2019
 

17 October 2019

 

Ideagen PLC

("Ideagen" "the Company" or "the Group")

 

Director/PDMR Dealing and Total Voting Rights

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces that David Hornsby, Executive Chairman of the Company, has exercised 1,833,333 options over new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") and subsequently sold 260,000 Ordinary Shares at a price of 147.5 pence per Ordinary Share. Following the exercise and sale Mr. Hornsby's beneficial interest has increased by 1,573,333 Ordinary Shares to 10,224,741 Ordinary Shares representing 4.6 per cent. of the total voting rights of the Company.

In addition, Alex Hewitt, Chief Legal Officer of the Company, has exercised 380,000 options and sold 380,000 Ordinary Shares at a price of 147.5 pence per Ordinary Share. Following the exercise and sale Mr. Hewitt now has a beneficial interest in 5,750 Ordinary Shares representing less than 0.1 per cent. of the total voting rights of the Company.

Application has been made to the London Stock Exchange for the 2,213,333 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 23 October 2019.

After Admission, the total number of Ordinary Shares in issue will be 223,582,702 and the total number of voting rights will therefore be 223,582,702. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The information communicated in this announcement includes inside information for the purposes of Article 7 of Regulation 596/2014

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive Officer

Graeme Spenceley, Chief Financial Officer

 

finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (Nomad)

Alice Lane (ECM)

 

Canaccord Genuity Limited

 020 7523 8000

Simon Bridges

Richard Andrews

 

 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides IRM software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Hornsby

2.

Reason for the Notification

a)

Position/status

Executive Chairman

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

9 pence

 1,333,333

22.38 pence

500,000

d)

Aggregated information:

·; Aggregated volume

·; Price

Exercise of options over 1,833,333 ordinary shares of 1p each

e)

Date of the transaction

17 October 2019 2019

f)

Place of the transaction

Outside trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Hornsby

2.

Reason for the Notification

a)

Position/status

Executive Chairman

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

147.5p

 260,000

d)

Aggregated information:

·; Aggregated volume

·; Price

Sale of 260,000 ordinary shares at 147.5 pence per share

e)

Date of the transaction

17 October 2019

f)

Place of the transaction

London stock exchange , AIM

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alex Hewitt

2.

Reason for the Notification

a)

Position/status

Chief Legal Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

37.63

380,000

d)

Aggregated information:

·; Aggregated volume

·; Price

Exercise of options over 380,000 ordinary shares of 1p each

e)

Date of the transaction

17 October 2019

f)

Place of the transaction

Outside trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alex Hewitt

2.

Reason for the Notification

a)

Position/status

Chief Legal Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

147.5p

380,000

d)

Aggregated information:

·; Aggregated volume

·; Price

Sale of 380,000 ordinary shares at 147.5p per share

e)

Date of the transaction

17 October 2019

f)

Place of the transaction

London stock exchange , AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFMMMGDNMGLZM
Date   Source Headline
25th Jun 20147:00 amRNSAcquisition of EIBS Ltd
5th Jun 20142:06 pmRNSHolding(s) in Company
3rd Jun 20147:00 amRNSIssue of ordinary shares
16th May 20147:00 amRNSIssue of ordinary shares
7th May 20147:00 amRNSTrading Update and Further NHS Contract Wins
17th Mar 20147:00 amRNSNHS Contract Wins
4th Mar 20147:00 amRNSContract Wins and Trading Update
20th Jan 201411:54 amRNSHolding(s) in Company
14th Jan 20147:00 amRNSHalf Yearly Report
3rd Jan 20144:41 pmRNSSecond Price Monitoring Extn
3rd Jan 20144:35 pmRNSPrice Monitoring Extension
17th Dec 20137:00 amRNSNotice of Results
20th Nov 20137:00 amRNSAcquisition of Pentana Ltd
6th Nov 20137:00 amRNSTrading update
30th Oct 201312:22 pmRNSAnnual Report & Accounts
29th Oct 20132:38 pmRNSResult of AGM
16th Oct 201312:02 pmRNSHolding(s) in Company
8th Oct 20137:00 amRNSIssue of ordinary shares
7th Oct 20137:00 amRNSNotice of AGM
9th Sep 20137:00 amRNSFurther Healthcare Contract Wins
16th Jul 20137:01 amRNSFinal Results
16th Jul 20137:00 amRNSNew Contract Win worth £300k
9th Jul 20137:00 amRNSNotice of Results
3rd Jul 20137:00 amRNSAcquisition of MSS Management Systems Services Ltd
10th Jun 20137:00 amRNSStrategic Partnership
10th May 20131:15 pmRNSDirector/PDMR Shareholding
10th May 20137:00 amRNSVA Contract Update
7th May 20137:00 amRNSTrading Update
22nd Apr 20137:00 amRNSContract Wins and Trading Update
19th Mar 20132:39 pmRNSHolding(s) in Company
12th Mar 20137:00 amRNSContract Wins and Board Change
31st Jan 20137:00 amRNSIssue of Equity and Award of Options
22nd Jan 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSHealthcare Contract Wins and New Appointments
16th Jan 20137:00 amRNSHolding(s) in Company
10th Jan 20137:00 amRNSNotice of Results
7th Jan 201312:55 pmRNSResult of General Meeting and Issue of Equity
24th Dec 20121:07 pmRNSHolding(s) in Company
24th Dec 201212:21 pmRNSHolding(s) in Company
19th Dec 20123:00 pmRNSPosting of Circular and Notice of General Meeting
17th Dec 20127:00 amRNSPlacing and acquisition
29th Nov 20127:00 amRNSTrading Update
9th Nov 20124:16 pmRNSHolding(s) in Company
31st Oct 20121:40 pmRNSResult of AGM
10th Oct 20125:57 pmRNSHolding(s) in Company
8th Oct 201211:42 amRNSNotice of AGM and Change of Address
3rd Sep 20128:25 amRNSHolding(s) in Company
29th Aug 20127:00 amRNSHolding(s) in Company
29th Aug 20127:00 amRNSContract Win
24th Jul 20127:00 amRNSPreliminary Results 30 April 2012

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.